Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Catino

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Gynaecological Oncology|January 1, 1992
Krukenberg tumor. A report of six casesG Gargano, A Catino, M Correale, et al.
European Journal of Gynaecological Oncology|January 1, 1995
Ovarian fibroma. A report of three casesG Gargano, F A Zito, A Catino, et al.
International Journal of Oncology|June 14, 2002
Epithelial ovarian cancer: second and third line chemotherapy (review)A Latorre, M De Lena, A Catino, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Serum vascular endothelial growth factor concentrations in hepatocellular cancer patients undergoing percutaneously radiofrequency thermal ablationC Gadaleta, M Coviello, A Catino, et al.
Minerva Medica|July 1, 1992
[The determination of sialic acid in cancer patients]M Correale, I Abbate, G Gargano, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Radiofrequency thermal ablation of 69 lung neoplasmsC Gadaleta, A Catino, G Ranieri, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Serum levels of TAG 72 and CA 15.3 in patients with gynaecological neoplasmsM Correale, I Abbate, A Catino, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasmsI Abbate, M Correale, G Gargano, et al.
International Journal of Oncology|June 6, 1998
Neoadjuvant chemotherapy with accelerated CNF plus G-CSF in patients with breast cancer tumors larger than three centimeters: a pilot studyV Lorusso, A Catino, F Schittulli, et al.
The International Journal of Biological Markers|January 1, 1992
Analytical and clinical evaluation of a new tumor marker in breast cancer: CA 27.29M Correale, I Abbate, G Gargano, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Gynaecological Oncology|January 1, 1992
Krukenberg tumor. A report of six casesG Gargano, A Catino, M Correale, et al.
European Journal of Gynaecological Oncology|January 1, 1995
Ovarian fibroma. A report of three casesG Gargano, F A Zito, A Catino, et al.
International Journal of Oncology|June 14, 2002
Epithelial ovarian cancer: second and third line chemotherapy (review)A Latorre, M De Lena, A Catino, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Serum vascular endothelial growth factor concentrations in hepatocellular cancer patients undergoing percutaneously radiofrequency thermal ablationC Gadaleta, M Coviello, A Catino, et al.
Minerva Medica|July 1, 1992
[The determination of sialic acid in cancer patients]M Correale, I Abbate, G Gargano, et al.
Journal of Chemotherapy (Florence, Italy)|January 29, 2005
Radiofrequency thermal ablation of 69 lung neoplasmsC Gadaleta, A Catino, G Ranieri, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Serum levels of TAG 72 and CA 15.3 in patients with gynaecological neoplasmsM Correale, I Abbate, A Catino, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Tumor necrosis factor and soluble interleukin-2 receptor: two immunological biomarkers in female neoplasmsI Abbate, M Correale, G Gargano, et al.
International Journal of Oncology|June 6, 1998
Neoadjuvant chemotherapy with accelerated CNF plus G-CSF in patients with breast cancer tumors larger than three centimeters: a pilot studyV Lorusso, A Catino, F Schittulli, et al.
The International Journal of Biological Markers|January 1, 1992
Analytical and clinical evaluation of a new tumor marker in breast cancer: CA 27.29M Correale, I Abbate, G Gargano, et al.
Pageof 4